Researchers Indicate That New Drug Shows Promise in Treating Mesothelioma
Mesothelioma cancer patients given pegargiminase had a 29% lower risk of death and 35% lower risk of disease progression in a recent clinical study.
Mesothelioma cancer patients given pegargiminase had a 29% lower risk of death and 35% lower risk of disease progression in a recent clinical study.